Expression of CMTM6 can affect the presence of programmed death ligand-1 (PDL1/CD274) at the surface of cells in a tumor environment at least in vitro, a possible mechanism to regulate anti-tumor immunity29,30. This evidence concerns the gene CMTM6 and neoplasm.